(Q45332279)

13 December 2017

Potential drug-drug interactions within Veterans Affairs medical centers (English)

1 reference

13 December 2017

0 references

0 references

9

1 reference

13 December 2017

Maysaa Mahmood

1

1 reference

13 December 2017

Daniel C Malone

2

1 reference

13 December 2017

Grant H Skrepnek

3

1 reference

13 December 2017

Jacob Abarca

4

1 reference

13 December 2017

Edward P Armstrong

5

1 reference

13 December 2017

John E Murphy

6

1 reference

13 December 2017

Amy J Grizzle

7

1 reference

13 December 2017

Yu Ko

8

1 reference

13 December 2017

1 July 2007

1 reference

American Journal of Health-System Pharmacy

13 December 2017

1 reference

13 December 2017

64

1 reference

13 December 2017

1500-1505

1 reference

13 December 2017

14

1 reference

The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group

13 December 2017

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060548

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060548

Drug-Related Morbidity and Mortality

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060548

Exposure to potential drug interactions in primary health care

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060548

Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060548

Prospective evaluation of adverse drug interactions in the emergency department

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060548

Drug interactions in surgical patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060548

Using a computerized drug prescription screening system to trace drug interactions in an outpatient setting.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060548

Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060548

Assessment of potential drug-drug interactions with a prescription claims database

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060548

Increase in US medication-error deaths between 1983 and 1993.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060548

Drug interactions in primary care: impact of a new algorithm on risk determination

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060548

Drug-drug interactions in the elderly

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060548

Preventing drug interactions by online prescription screening in community pharmacies and medical practices

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060548

Pharmacy data in the VA health care system

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060548

Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060548

Potential determinants of drug-drug interaction associated dispensing in community pharmacies.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060548

31 March 2020

The Serotonin Syndrome

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060548

Drug-drug interactions: proof of relevance (part I).

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060548

Systematic overview of warfarin and its drug and food interactions

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060548

Bleeding complications in patients on celecoxib and warfarin

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060548

Computer decision support systems

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060548

Complexity of medication use in the Veterans Affairs healthcare system: Part II. Antidepressant use among younger and older outpatients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060548

Effect of computerized physician order entry and a team intervention on prevention of serious medication errors

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060548

Incidence and possible causes of prescribing potentially hazardous/contraindicated drug combinations in general practice

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060548

Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060548

Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060548

Drug interaction management

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060548

Clinical relevance of drug-drug interactions : a structured assessment procedure

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060548

31 March 2020

Identifiers

DOI

10.2146/AJHP060548

1 reference

13 December 2017

1 reference